Sienna Biopharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Sep '19 Sep 30, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Cash & Equivalents	11.33	48.53	74.47	9.09	4.96
Cash & Short-Term Investments	11.33	48.53	74.47	9.09	4.96
Cash Growth	-82.29%	-34.84%	719.13%	83.21%	-
Prepaid Expenses	8.19	1.71	2.7	1.32	0.62
Restricted Cash	0.21	0.18	0.18	0.11	0.04
Other Current Assets	-	-	-	-	0.02
Total Current Assets	19.73	50.41	77.35	10.52	5.64
Property, Plant & Equipment	0.26	0.31	0.43	0.29	0.11
Goodwill	-	10.99	11.47	9.7	-
Long-Term Deferred Charges	23.5	45.59	47.6	41.86	-
Other Long-Term Assets	-	-	-	0	-
Total Assets	43.49	107.31	136.85	62.38	5.75
Accounts Payable	1.83	2.79	2.36	1.69	0.81
Accrued Expenses	2.88	7.84	5.65	3.06	0.2
Other Current Liabilities	-	13.71	0.23	5.14	-
Total Current Liabilities	4.93	24.35	8.24	9.88	1.01
Long-Term Debt	10.1	30.13	-	-	-
Long-Term Deferred Tax Liabilities	5.36	10.5	10.96	9.33	-
Other Long-Term Liabilities	-	15.75	26.44	21.05	0.69
Total Liabilities	20.39	80.73	45.65	40.26	1.7
Common Stock	-	-	-	0	0
Additional Paid-In Capital	209.82	182.75	171.73	-	-
Retained Earnings	-188.02	-159.37	-85.9	-35.35	-14.19
Comprehensive Income & Other	1.3	3.2	5.37	-2.05	-2.11
Total Common Equity	23.1	26.58	91.2	-37.4	-16.3
Shareholders' Equity	23.1	26.58	91.2	22.12	4.05
Total Liabilities & Equity	43.49	107.31	136.85	62.38	5.75
Total Debt	10.28	30.13	-	-	-
Net Cash (Debt)	1.05	18.4	74.47	9.09	4.96
Net Cash Growth	-96.90%	-75.29%	719.13%	83.21%	-
Net Cash Per Share	0.04	0.90	7.65	5.37	2.90
Filing Date Shares Outstanding	30.76	30.07	20.19	1.72	1.69
Total Common Shares Outstanding	30.77	20.87	20.19	1.72	1.69
Working Capital	14.8	26.06	69.11	0.64	4.63
Book Value Per Share	0.75	1.27	4.52	-21.75	-9.65
Tangible Book Value	23.1	15.59	79.73	-47.1	-16.3
Tangible Book Value Per Share	0.75	0.75	3.95	-27.39	-9.65
Machinery	0.42	0.54	0.51	0.35	0.12
Leasehold Improvements	0.11	0.11	0.11	0.02	-

Source: S&P Capital IQ. Standard template. Financial Sources.